Drug class
Trimethoprim
Trimethoprim is a synthetic antibacterial agent that functions as a folate antagonist and dihydrofolate reductase inhibitor. Read more about Trimethoprim
45 drugs in this class 37 manufacturers
Drugs in Trimethoprim
SULFAMETHOXAZOLE-TRIMETHOPRIM (sulfamethoxazole/trimethoprim)
SULFAMETHOXAZOLE-TRIMETHOPRIM (sulfamethoxazole/trimethoprim)
SULFAMETHOXAZOLE-TRIMETHOPRIM (sulfamethoxazole/trimethoprim)
SULFAMETHOXAZOLE-TRIMETHOPRIM (sulfamethoxazole/trimethoprim)
TRIMETHOPRIM
SULFAMETHOXAZOLE-TRIMETHOPRIM (sulfamethoxazole/trimethoprim)
TRIMETHOPRIM
SULFAMETHOXAZOLE-TRIMETHOPRIM (sulfamethoxazole/trimethoprim)
Trimethoprim is a synthetic antibacterial agent that functions as a folate antagonist and dihydrofolate reductase inhibitor.
While often referred to in clinical reference tools as its own class or subclass, it represents a specific active pharmaceutical ingredient within the broader antifolate class.
Mechanistically, it selectively and reversibly inhibits bacterial dihydrofolate reductase, preventing the conversion of dihydrofolic acid to active tetrahydrofolic acid and consequently halting essential bacterial nucleic acid and protein synthesis.
Trimethoprim is widely utilized as monotherapy for initial episodes of uncomplicated urinary tract infections, and it is frequently co-formulated with sulfamethoxazole to manage respiratory tract infections, acute otitis media, gastrointestinal infections, and opportunistic conditions such as Pneumocystis jirovecii pneumonia.
-
nih.gov
Trimethoprim is a synthetic antibacterial agent that functions as a folate antagonist and dihydrofolate reductase inhibitor While often referred to in clinical reference tools as its own class or subclass, it represents a specific active pharmaceutical ingredient within the broader antifolate class
-
drugbank.com
Trimethoprim is a synthetic antibacterial agent that functions as a folate antagonist and dihydrofolate reductase inhibitor Mechanistically, it selectively and reversibly inhibits bacterial dihydrofolate reductase, preventing the conversion of dihydrofolic acid to active tetrahydrofolic acid and consequently halting essential bacterial nucleic acid and protein synthesis
-
drugbank.com
While often referred to in clinical reference tools as its own class or subclass, it represents a specific active pharmaceutical ingredient within the broader antifolate class
-
nih.gov
Mechanistically, it selectively and reversibly inhibits bacterial dihydrofolate reductase, preventing the conversion of dihydrofolic acid to active tetrahydrofolic acid and consequently halting essential bacterial nucleic acid and protein synthesis
-
nih.gov
Trimethoprim is widely utilized as monotherapy for initial episodes of uncomplicated urinary tract infections, and it is frequently co-formulated with sulfamethoxazole to manage respiratory tract infections, acute otitis media, gastrointestinal infections, and opportunistic conditions such as Pneumocystis jirovecii pneumonia
-
nih.gov
Trimethoprim is widely utilized as monotherapy for initial episodes of uncomplicated urinary tract infections, and it is frequently co-formulated with sulfamethoxazole to manage respiratory tract infections, acute otitis media, gastrointestinal infections, and opportunistic conditions such as Pneumocystis jirovecii pneumonia
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.